Skip to main content

Determinants of p14/ARF Methylation in Healthy Females: Association with Reproductive and Non-Reproductive Risk Factors of Breast Cancer

Research Authors
Ghada M. Ezzat1, Mahmoud H. El-Shoeiby 2
Research Department
Research Journal
Egyptian Journal of Medical Human Genetics 2019 20:22;1-7 SJR 0.264 (2018)
Research Publisher
NULL
Research Rank
2
Research Vol
NULL
Research Website
NULL
Research Year
2019
Research_Pages
NULL
Research Abstract

Background: DNA methylation is associated with the risk factors of breast cancer. However, the impact of the reproductive and non-reproductive risk factors of breast cancer on p14/ARF methylation is not well-known. Therefore, we investigated the relationships between p14/ARF methylation percentage and risk factors of breast cancer including age, family history, obesity, and reproductive risk factors in 120 breast cancer-free subjects; 60 women with a first-degree family history of breast cancer and 60 age-matched women with no family history of breast cancer. Extracted DNA from the whole blood was bisulfite-treated by EZ-DNA modification kit. Quantitative methylation of p14/ARF was analyzed by methylation-specific PCR then methylation percentage of p14/ARF was calculated.
‏ Results: P14/ARF methylation percentage was not related to any of the risk factors of breast cancer except age. Our study showed that p14/ARF methylation percentage was significantly higher in females with age ≥ 40 years than in females with age < 40 years (p< 0.001). Also, a positive significant correlation between the p14/ARF methylation percentage and age was detected (r= 0.285, p= 0.014). Furthermore, univariate regression analysis showed that the age is independently associated with high p14/ARF methylation percentage (β=1. 46, p=0.029)‏.
Conclusion: Among healthy females, the age is strongly linked to the peripheral p14/ARF methylation percentage. The present study suggests that p14/ARF methylation is not associated with other breast cancer risk factors. These results need oncoming research on a large cohort to define the interactions between p14/ARF methylation and the risk factors of breast cancer.